Pharmaceuticals Market

`

Sort By

1-10 of 17

Page:
  1. 1
  2. 2
  1. Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
    19
    Sep 2018

    Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

    Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

    Region : North America

    The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
    USD 4,950.00
    Read More
  2. Growth Insights—Real World Evidence Analytics Solutions Market
    24
    Apr 2018

    Growth Insights—Real World Evidence Analytics Solutions Market

    Innovation and Changing End-user Needs Driving Market Growth

    Region : North America

    Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...
    USD 3,000.00
    Read More
  3. Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
    12
    Apr 2018

    Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action

    Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth

    Region : Europe

    The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
    USD 3,000.00
    Read More
  4. Global Biologics Market—Companies-to-Action
    20
    Nov 2017

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    Region : North America

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
    USD 3,000.00
    Read More
  5. East African Pharmaceutical Market, Forecast to 2021
    27
    Sep 2017

    East African Pharmaceutical Market, Forecast to 2021

    Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

    Region : Africa

    Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...
    USD 4,950.00
    Read More
  6. Biomarkers Enabling Diabetes and Obesity Management
    02
    Mar 2017

    Biomarkers Enabling Diabetes and Obesity Management

    Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

    Region : Global

    Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...
    USD 4,950.00
    Read More
  7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
    16
    Aug 2016

    Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

    Emerging Business Models Drive Transformation

    Region : North America

    The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...
    USD 7,000.00
    Read More
  8. 2016 Indonesia Transformational Health Insights
    31
    May 2016

    2016 Indonesia Transformational Health Insights

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    Region : Asia Pacific

    Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...
    USD 1,500.00
    Read More
  9. Pharmaceutical Market Access Strategy for Ethiopia
    27
    May 2016

    Pharmaceutical Market Access Strategy for Ethiopia

    Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain

    Region : Africa

    Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...
    USD 4,950.00
    Read More
  10. Vital Signs The Analyst's Perspective - April 2016 Issue
    24
    May 2016
    This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
    USD 450.00
    Read More

Sort By

1-10 of 17

Page:
  1. 1
  2. 2